Targeting skull bone marrow hematopoiesis for the treatment of childhood brain tumors

Key Points

• Targeting skull marrow hematopoiesis shows promise in treating childhood brain tumors.
• Increased hematopoiesis from skull bone marrow correlated with better tumor responses.
• Analysis focuses on the tumor microenvironment and its interaction with hematopoiesis.
• Implications indicate that interventions affecting marrow could enhance treatment efficacy.